LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
30.64
-0.17 (-0.55%)
At close: Oct 29, 2025, 4:00 PM EDT
30.64
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:10 PM EDT
LENZ Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts that cover LENZ Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $56.25, which forecasts a 83.58% increase in the stock price over the next year. The lowest target is $50 and the highest is $67.
Price Target: $56.25 (+83.58%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Reiterates $40 → $50 | Buy | Reiterates | $40 → $50 | +63.19% | Oct 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 → $67 | Buy | Maintains | $51 → $67 | +118.67% | Oct 10, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $49 → $52 | Strong Buy | Maintains | $49 → $52 | +69.71% | Aug 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $56 | Strong Buy | Maintains | $48 → $56 | +82.77% | Aug 1, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $49 | Strong Buy | Maintains | $45 → $49 | +59.92% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
13.15M
Revenue Next Year
50.73M
from 13.15M
Increased by 285.82%
EPS This Year
-2.68
from -2.34
EPS Next Year
-2.61
from -2.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 16.8M | 63.3M | |
| Avg | 13.1M | 50.7M | |
| Low | 5.9M | 40.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 381.4% | |
| Avg | - | 285.8% | |
| Low | - | 206.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.57 | -2.09 | |
| Avg | -2.68 | -2.61 | |
| Low | -2.73 | -3.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.